// App-Quantinova.ai

: Large-scale genome-wide meta-analyses provide insights for the development of new disease modifying targets for osteoarthritis

Researchers

Presenter

  • K. Hatzikotoulas

Principal Investigators

  • C. Boer

  • L. Southam

  • L. Stefansdottir

  • Y. Zhang

  • R. de Almeida

  • J. Zheng

  • A. Barysenka

  • I. Meulenbelt

  • U. Styrkarsdottir

  • J. van Meurs

  • M. Lee

  • E. Zeggini

Medical Centers

  • Inst. of Translational Genomics, Helmholtz Zentrum München, German Res. Ctr. for Environmental Hlth., Neuherberg, Germany

  • Dept. of Internal medicine, Erasmus MC, Med. Ctr., Rotterdam, Netherlands

  • deCODE genetics, Amgen, Sturlugata 8, IS101 Reykjavik, Iceland

  • Genomic Med. Inst., Geisinger Hlth.System, Danville, 17822, PA, USA

  • Dept. of BioMed. Data Sci., Section Molecular Epidemiology, Leiden Univ. Med. Ctr., 2300 RC Leiden, Netherlands

  • MRC Integrative Epidemiology Unit, University of Bristol., Bristol, United Kingdom

Locations

  • Germany

  • Netherlands

  • Iceland

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Osteoarthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved